Sharon Fekrat, MD
Department / Division
Ophthalmology /
Retinal Ophthalmology
Address
DUMC 3802
Durham, NC 27710
Appointment Telephone
919-681-3937
Office Telephone
919-684-1857
Fax Telephone
919-681-6474
- MD, University of Chicago Pritzker School of Medicine (Illinois), 1991
- Internal Medicine, Greater Baltimore Medical Center (Maryland), 1991-1992
- Ophthalmology, Wilmer Ophthalmological Institute, Johns Hopkins Medical Institutions (Maryland), 1992-1995
- Medical Retina, Wilmer Ophthalmological Institute, Johns Hopkins Medical Institutions (Maryland), 1995-1996
- Vitreoretinal Surgery, Wilmer Ophthalmological Institute, Johns Hopkins Medical Institutions (Maryland), 1996-1997
- Fellow, American College of Surgeons
Clinical Interests
Complete medical and surgical evaluation and treatment of vitreoretinal diseases including retinal vein occlusion, diabetic retinopathy, macular degeneration, eye trauma, macular holes, epiretinal membranes, retinal detachment, proliferative vitreoretinopathy
Research Interests
Dr.Fekrat's research interests include treatment options for retinal vein occlusion and neovascular age-related macular degeneration. She is investigating new treatment options for these entities that are on the forefront of medical care. She is the Founder and Director of the new Duke Retinal Vein Occlusion Center of Excellence. www.dukeRVO.com
This faculty member has no reported relationships with industry.
Representative Publications
Ahmad, S; Bearelly, S; Stinnett, SS; Cooney, MJ; Fekrat, S. Photodynamic therapy for predominantly hemorrhagic lesions in neovascular age-related macular degeneration. American Journal of Ophthalmology. 2008;145:1052-1057.
(2008)
Abstract
Etter, J; Fekrat, S. Pars plana vitrectomy and internal limiting membrane peeling in an eye with foveal lipid deposition after focal laser surgery for diabetic macular edema. Canadian Journal of Ophthalmology. 2008;43:373-374.
(2008)
Abstract
Im, L; Allingham, RR; Singh, I; Stinnett, S; Fekrat, S. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection. Journal of Glaucoma. 2008;17:128-132.
(2008)
Abstract
Melamud, A; Stinnett, S; Fekrat, S. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections. American Journal of Ophthalmology. 2008;146:91-95.
(2008)
Abstract
Ramchandran, RS; Fekrat, S; Stinnett, SS; Jaffe, GJ. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results. American Journal of Ophthalmology. 2008;146:285-291.
(2008)
Abstract
Park, CH; Scott, AW; Fekrat, S. Effect of oral pentoxifylline on cystoid macular edema associated with central retinal vein occlusion. Retina: the Journal of Retinal and Vitreous Diseases. 2007;27:1020-1025.
(2007)
Abstract
Bearelly, S; Cooney, MJ; Stinnett, S; Fekrat, S. Intravitreal triamcinolone for cystoid macular edema related to branch retinal vein occlusion. Annals of Ophthalmology. 2006;38:317-320.
(2006)
Abstract
Mahmoud, TH; Peng, YW; Proia, AD; Davidson, M; Deramo, VA; Fekrat, S. Recombinant tissue plasminogen activator injected into the vitreous cavity may penetrate the retinal veins of a porcine model of vascular occlusion. British Journal of Ophthalmology. 2006;90:911-915.
(2006)
Abstract
Mruthyunjaya, P; Wirostko, WJ; Chandrashekhar, R; Stinnett, S; Lai, JC; Deramo, V; Tang, J; Dev, S; Postel, EA; Connor, TB; Fekrat, S. Central retinal vein occlusion in patients treated with long-term warfarin sodium (Coumadin) for anticoagulation. Retina: the Journal of Retinal and Vitreous Diseases. 2006;26:285-291.
(2006)
Abstract
Shuler, RK; Fekrat, S. Does radial optic neurotomy alter retinal blood flow in eyes with a central retinal vein occlusion?. American Journal of Ophthalmology. 2006;141:145-146.
(2006)
Abstract
Smith, BT; Park, CH; Fekrat, S. Hemi-retinal vein occlusion following LASIK. Annals of Ophthalmology. 2006;38:139-140.
(2006)
Abstract
